Medically reviewed by Qin Rao, MD Metabolic dysfunction-associated steatohepatitis (MASH)—previously known as nonalcoholic ...

The liver is essential for digestion, metabolism, detoxification, and fluid regulation. While alcohol abuse is a known cause ...

Researchers identify the Asah1 gene as a promising target for novel therapies to treat nonalcoholic fatty liver disease ...

NASH) and scarring (liver fibrosis), which can lead to cirrhosis or even liver cancer. Therefore, understanding how NAFLD progresses to fibrotic NASH is important for improving the outcomes of ...

The liver is the body’s chemical factory, where most metabolic processes take place. It processes everything you eat and drink, converting them into energy and essential nutrients. Additionally, the ...

Discover preclinical studies that indicate that empagliflozin reduces liver fat, improves liver function markers, and ...

Health experts highlight the importance of maintaining liver health due to the rising concern over fatty liver conditions.

with non-alcoholic steatohepatitis (NASH) and liver fibrosis as intermediate stages. Dr Rajesh Battina revealed, “Some genetic factors also play a significant role. It is also associated with ...

Promising Nonalcoholic Steatohepatitis Therapies such as AZD2693, Saroglitazar Magnesium 4 mg, Semaglutide (SEMA), Cilofexor ...

The global liver fibrosis treatment market is poised for substantial growth, with revenue projections increasing from USD 17.51 billion in 2024 to USD 51.16 billion by 2033. This expansion represents ...

Hepatic fat accumulation can progress from simple NAFLD to non-alcoholic steatohepatitis (NASH) which includes hepatocellular injury, inflammation, and fibrosis. In more severe cases, complications ...